Advertisement
PLRX vs SION
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and SION is a Hold.
Momentum Indicator for PLRX turns negative, indicating new downward trend
PLRX saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 72 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
PLRX moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PLRX crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for PLRX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PLRX's RSI Oscillator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLRX advanced for three days, in 197 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
PLRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. PLRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.365) is normal, around the industry mean (2.973). P/E Ratio (-0.577) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. PLRX's P/S Ratio (3333.333) is slightly higher than the industry average of (438.009).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for SION turns negative, indicating new downward trend
SION saw its Momentum Indicator move below the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator turned negative. In 33 of the 38 cases, the stock moved further down in the following days. The odds of a decline are at 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SION declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for SION entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where SION advanced for three days, in 99 of 114 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
SION may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.646) is normal, around the industry mean (2.973). P/E Ratio (-1.767) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. SION’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SION’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PLRX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 82 | |
P/E GROWTH RATING 1..100 | 21 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PLRX | SION | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 87% | 5 days ago 87% |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 80% |
| Advances ODDS (%) | 15 days ago 74% | 4 days ago 87% |
| Declines ODDS (%) | 2 days ago 85% | 2 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 58% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PLRX’s FA Score shows that 1 FA rating(s) are green while SION’s FA Score has 1 green FA rating(s).
- PLRX’s FA Score: 1 green, 4 red.
- SION’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PLRX’s TA Score shows that 4 TA indicator(s) are bullish while SION’s TA Score has 4 bullish TA indicator(s).
- PLRX’s TA Score: 4 bullish, 5 bearish.
- SION’s TA Score: 4 bullish, 3 bearish.
Price Growth
PLRX (@Biotechnology) experienced а -11.01% price change this week, while SION (@Biotechnology) price change was -6.86% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was -16.27%, and the average quarterly price growth was -16.72%.
Reported Earning Dates
PLRX is expected to report earnings on Nov 05, 2026.
SION is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Biotechnology (+1.28% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
PLRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.
| Ticker / NAME | Correlation To PLRX | 1D Price Change % | ||
|---|---|---|---|---|
| PLRX | 100% | -2.31% | ||
| LXRX - PLRX | 58% Loosely correlated | -4.49% | ||
| SION - PLRX | 43% Loosely correlated | -1.81% | ||
| ABEO - PLRX | 37% Loosely correlated | -0.89% | ||
| RANI - PLRX | 36% Loosely correlated | -2.88% | ||
| AXSM - PLRX | 35% Loosely correlated | -0.15% | ||
More | ||||
SION and
Correlation & Price change
A.I.dvisor indicates that over the last year, SION has been closely correlated with TENX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SION jumps, then TENX could also see price increases.
| Ticker / NAME | Correlation To SION | 1D Price Change % | ||
|---|---|---|---|---|
| SION | 100% | -1.81% | ||
| TENX - SION | 92% Closely correlated | +7.98% | ||
| PLRX - SION | 43% Loosely correlated | -2.31% | ||
| MGTX - SION | 42% Loosely correlated | -0.91% | ||
| HRTX - SION | 41% Loosely correlated | -12.57% | ||
| BCAX - SION | 40% Loosely correlated | -1.68% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DBO | 26.00 | 0.35 | +1.36% |
| Invesco DB Oil Fund (DBO) | |||
| KNOV | 31.44 | N/A | +0.01% |
| Innovator U.S. Small Cap Power Buffer ETF - November (KNOV) | |||
| DRAI | 32.55 | N/A | N/A |
| Draco Evolution AI ETF (DRAI) | |||
| ABLS | 21.50 | N/A | N/A |
| Abacus FCF Small Cap Leaders ETF (ABLS) | |||
| CRBN | 252.83 | -3.44 | -1.34% |
| iShares Low Carbon Optimized MSCI ACWI ETF (CRBN) | |||